Corporate ActionJun 9, 2026, 06:56 PM
Parabilis Medicines Increases Common Stock Offering by 191,666 Shares
AI Summary
Parabilis Medicines, Inc. filed an S-1MEF registration statement to increase the number of common shares offered. The company registered an additional 191,666 shares, which includes 25,000 shares for the underwriters' option to purchase additional shares. This filing was made pursuant to Rule 462(b) and incorporates by reference the contents of the earlier effective Registration Statement on Form S-1 (File No. 333-296032).
Key Highlights
- Filed S-1MEF to increase the aggregate number of shares of common stock offered.
- Additional 191,666 shares of common stock registered for issuance and sale.
- Includes 25,000 shares subject to purchase upon exercise of underwriters' option.
- Filed pursuant to Rule 462(b) under the Securities Act of 1933.
- References prior Registration Statement on Form S-1 (File No. 333-296032).
- Additional shares represent no more than 20% of the maximum aggregate offering price.
Price Impact